Technical Analysis for ARGSQ - Argos Therapeutics

Grade Last Price % Change Price Change
grade D 0.0536 19.11% 0.0086
ARGSQ closed up 19.11 percent on Tuesday, September 24, 2019, on 1.13 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical ARGSQ trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 19.11%
Stochastic Sell Signal Bearish 19.11%
Wide Bands Range Expansion 19.11%
Lower Bollinger Band Touch Weakness 19.11%
Fell Below 20 DMA Bearish 0.00%
Weak + Overbought Other 0.00%
Wide Bands Range Expansion 0.00%

Older signals for ARGSQ ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on its proprietary technology platform, Arcelis. Its product candidates include rocapuldencel-T, which is in Phase III clinical trial for the treatment of metastatic renal cell carcinoma. The company also develops AGS-004, which is in Phase II clinical trials for the treatment of human immunodeficiency virus. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is based in Durham, North Carolina. As of February 13, 2019, Argos Therapeutics Inc. operates as a subsidiary of Genexine Inc. and SCM Lifescience Co.
Cancer Infectious Diseases Treatment Of Cancer Cancer Immunotherapy Immunotherapies Ags 004 Arcelis Immunotherapies Based On Its Proprietary Technology Metastatic Renal Cell Carcinoma
Is ARGSQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.1045
52 Week Low 0.019
Average Volume 6,615
200-Day Moving Average 0.0
50-Day Moving Average 0.0591
20-Day Moving Average 0.0554
10-Day Moving Average 0.0552
Average True Range 0.0143
ADX 45.4
+DI 7.3515
-DI 20.0403
Chandelier Exit (Long, 3 ATRs ) 0.0201
Chandelier Exit (Short, 3 ATRs ) 0.0779
Upper Bollinger Band 0.0648
Lower Bollinger Band 0.046
Percent B (%b) 0.4
BandWidth 33.935018
MACD Line -0.002
MACD Signal Line -0.0017
MACD Histogram -0.0003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0815
Resistance 3 (R3) 0.0784 0.0660 0.0769
Resistance 2 (R2) 0.0660 0.0589 0.0676 0.0753
Resistance 1 (R1) 0.0598 0.0545 0.0629 0.0629 0.0737
Pivot Point 0.0474 0.0474 0.0490 0.0490 0.0474
Support 1 (S1) 0.0412 0.0403 0.0443 0.0443 0.0335
Support 2 (S2) 0.0288 0.0359 0.0304 0.0319
Support 3 (S3) 0.0226 0.0288 0.0304
Support 4 (S4) 0.0257